HOME >> MEDICINE >> NEWS
The cancer patient's journey: An uphill climb

Europe's leading cancer charity and the first cancer survivor ever to reach the summit of Mount Everest have teamed up to help others get the best help possible in the fight against cancer.

On 31 October, Sean Swarner will be speaking at the European Society for Medical Oncology's 3rd Patient Seminar, a meeting that provides a vital opportunity for cancer patients to hear about the latest in treatments from the world's top cancer doctors. The seminar makes the most of the fact that hundreds of leading oncologists are gathering for the 29th ESMO Congress to give cancer patients the latest news about chemotherapy and drugs. There are few fields in clinical medicine that are expanding as rapidly as oncology. "The patient seminar is a really fantastic idea, and I'm proud to be involved with it," Sean said. "I really wish something like this had been around in the early days for me."

Sean was diagnosed with final stage Hodgkin's disease at the age of 13, and given 3 months to live. After 10 months of chemotherapy the cancer went into remission, but just 18 months later doctors found a golf-ball sized tumor in his chest and told him he had just 14 days left to live.

Fourteen years later, he climbed Mt. Everest, the world's highest peak. "I remember when I was fighting cancer and all my friends were chasing girls, collecting baseball cards, and trying different styles with their hair - I had no hair," says Sean. "I had no girls who were interested in me because I was 60 lbs overweight, and I had no one to look up to, no models to encourage me. I felt so alone." "Climbing Everest was an attempt to become that support, that model, that encouragement, that inspiration to others who might not have someone to look up to," Sean says. "I wanted to become a beacon of hope to those battling cancer. I wanted to provide inspiration that they too can 'climb' out of their existing life and into an incredible one after the disease."

Se
'"/>

Contact: Gracemarie Bricalli
gracemarie@esmo.org
European Society for Medical Oncology
21-Oct-2004


Page: 1 2

Related medicine news :

1. Hormonal treatment improves survival in high-risk prostate cancer patients
2. International breast cancer prevention study launches in the United States and Canada
3. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
4. Cultural and social factors influence prostate cancer treatment
5. Primary care office strategies may increase colon cancer screening
6. Benefits of lung cancer screening with CT questioned
7. Three-year cervical cancer screening recommendations may be applicable for certain women with HIV
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
10. Employment prospects good for most cancer survivors -- but not all
11. New colorectal cancer screening recommendations for African Americans

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The cancer patient journey uphill climb

(Date:5/22/2013)... May 22, 2013 Digital Advertising Agency, ... behalf of its social media management client, Primal ... year's supply of the all-natural organic deodorant. The contest ... of the rapidly-growing start-up deodorant company based in Tampa, ... contest or sweepstakes on a Facebook page is a ...
(Date:5/22/2013)... NJ) John Theurer Cancer Center at Hackensack University Medical ... will bring together leading cancer experts, for presentation and ... therapy and interventional immunology in oncology, on Friday, June ... to bring together some of the nation,s top immunology ... cell therapies in oncology, both in solid and liquid ...
(Date:5/22/2013)... DiscountFurnaceFilter.com now offers a vast selection ... filters, dehumidifiers, fans, aroma diffusers, dehumidifiers and more. ... Form's product line to their selection! Stadler Form ... diffusers and dehumidifiers) to accentuate anyone’s home décor. ... perfect combination of design and functionality. Otto is ...
(Date:5/22/2013)... Garcinia cambogia select is a dual action ... the extra fat being stored in the body. For a ... This fat burner helps people in this regard by making ... Basically it does this by secreting a hormone serotonin which ... away from emotional overeating. In this way, it keeps a ...
(Date:5/22/2013)... NY (PRWEB) May 22, 2013 ... and Rensselaer Polytechnic Institute today announced an affiliation ... development of new diagnostic tools and treatments that ... a signing ceremony on May 22, 2013. , ... expertise—Rensselaer’s in engineering and invention prototyping and Mount ...
Breaking Medicine News(10 mins):Health News:Social Media Management Firm, 21Digital, Launches National Facebook Sweepstakes for Client, Primal Pit Paste 2Health News:Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies 2Health News:DiscountFurnaceFilter.com Now Offers Stadler Form Products - Providing Solutions to All Your Summer Needs 2Health News:Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 3Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 4Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 5Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 6Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 7
(Date:5/22/2013)... and TORONTO , May ... (OTCBB: GNBT) today announced three presentations demonstrating the superiority ... its wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ). ... of the American Society of Clinical Oncology (ASCO) to ... May 31 through June 4, 2013. The ...
(Date:5/22/2013)... Mai 2013  Grifols, ein globales Unternehmen ... Barcelona , Spanien, präsentierte die Ergebnisse ... Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel ... auf ein Niveau anhebt, das innerhalb des ... ATT-Mangel ist eine lebensbedrohliche, genetische Erkrankung, bei ...
(Date:5/22/2013)... , May 22, 2013  Medifocus, Inc. (OTCQX: MDFZF and ... , Chief Operating Officer, will present at the Second Annual ... New York City at the Grand ... to begin at 4:00 p.m. EDT and will be available ...   http://wsw.com/webcast/marcum/mfs.v/   For more information and registration, ...
Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3
Cached News: